Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013;18(9):963–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sneed JR, Rindskopf D, Steffens DC, Krishnan KR, Roose SP. The vascular depression subtype: evidence of internal validity. Biol Psychiatry. 2008;64(6):491–7.
Article
PubMed
PubMed Central
Google Scholar
Gonzalez HM, Tarraf W, Whitfield K, Gallo JJ. Vascular depression prevalence and epidemiology in the United States. J Psychiatr Res. 2012;46(4):456–61.
Article
PubMed
PubMed Central
Google Scholar
Culang-Reinlieb ME, Johnert LC, Brickman AM, Steffens DC, Garcon E, Sneed JR. MRI-defined vascular depression: a review of the construct. Int J Geriatr Psychiatry. 2011;26(11):1101–8.
PubMed
Google Scholar
Sneed JR, Culang-Reinlieb ME. The vascular depression hypothesis: an update. Am J Geriatr Psychiatry. 2011;19(2):99–103.
Article
PubMed
PubMed Central
Google Scholar
van Praag HM. Can stress cause depression? World J Biol Psychiatry. 2005;6 Suppl 2:5–22.
Article
PubMed
Google Scholar
Bella R, Ferri R, Cantone M, Pennisi M, Lanza G, Malaguarnera G, et al. Motor cortex excitability in vascular depression. Int J Psychophysiol. 2011;82(3):248–53.
Article
PubMed
Google Scholar
Brunoni AR, Bensenor IM, Alves TC. Therapeutic interventions for vascular depression: a systematic review. Rev Bras Psiquiatr. 2011;33(4):400–9.
Article
PubMed
Google Scholar
Iosifescu DV, Renshaw PF, Lyoo IK, Lee HK, Perlis RH, Papakostas GI, et al. Brain white-matter hyperintensities and treatment outcome in major depressive disorder. Br J Psychiatry. 2006;188:180–5.
Article
PubMed
Google Scholar
Taylor W, Kamil K, Zheen Z, Steffens D, MacFall J. Cingulum bundle white matter lesions influence antidepressant response in late-life depression: Apilotstudy. J Affect Disord. 2014;162:8–11.
Article
PubMed
PubMed Central
Google Scholar
Iosifescu DV, Clementi-Craven N, Fraguas R, Papakostas GI, Petersen T, Alpert JE, et al. Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder. Psychosom Med. 2005;67(5):703–6.
Article
PubMed
Google Scholar
Sheline YI, Pieper CF, Barch DM, Welsh-Bohmer K, McKinstry RC, MacFall JR, et al. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry. 2010;67(3):277–85.
Article
PubMed
PubMed Central
Google Scholar
Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006;59(12):1116–27.
Article
CAS
PubMed
Google Scholar
Breuillaud L, Rossetti C, Meylan EM, Merinat C, Halfon O, Magistretti PJ, et al. Deletion of CREB-regulated transcription coactivator 1 induces pathological aggression, depression-related behaviors, and neuroplasticity genes dysregulation in mice. Biol Psychiatry. 2012;72(7):528–36.
Article
CAS
PubMed
Google Scholar
Castren E, Rantamaki T. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol. 2010;70(5):289–97.
Article
CAS
PubMed
Google Scholar
Gudmundsson P, Skoog I, Waern M, Blennow K, Palsson S, Rosengren L, et al. The relationship between cerebrospinal fluid biomarkers and depression in elderly women. Am J Geriatr Psychiatry. 2007;15(10):832–8.
Article
PubMed
Google Scholar
Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D. Neurovascular unit dysfunction with blood–brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation. 2013;10:142.
PubMed
PubMed Central
Google Scholar
Zlokovic BV. Neurodegeneration and the neurovascular unit. Nat Med. 2010;16(12):1370–1.
Article
CAS
PubMed
Google Scholar
Huang SJ, Zhang XH, Wang YY, Pan JH, Cui HM, Fang SP, et al. Effects of Kaixin Jieyu Decoction on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model. Chin J Integr Med. 2014;20(4):280–5.
Article
PubMed
Google Scholar
Zhang XH, Huang SJ, Wang YY, Zhang Y, Pan JH, Zheng J, et al. Effects of Kaixin Jieyu Decoction on behavior and glial fibrillary acidic protein expression in cerebral hippocampus of a rat vascular depression model. Chin J Integr Med. 2015;21(3):223–8.
Article
PubMed
Google Scholar
Hritcu L, Gorgan LD. Intranigral lipopolysaccharide induced anxiety and depression by altered BDNF mRNA expression in rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2014;51:126–32.
Article
CAS
PubMed
Google Scholar
Kosel M, Brockmann H, Frick C, Zobel A, Schlaepfer TE. Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex. Psychiatry Res. 2011;191(3):153–9.
Article
PubMed
Google Scholar
Liu X, Wang Z, Wang P, Yu B, Liu Y, Xue Y. Green tea polyphenols alleviate early BBB damage during experimental focal cerebral ischemia through regulating tight junctions and PKCalpha signaling. BMC Complement Altern Med. 2013;13:187.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yatomi Y, Tanaka R, Shimura H, Miyamoto N, Yamashiro K, Takanashi M, et al. Chronic brain ischemia induces the expression of glial glutamate transporter EAAT2 in subcortical white matter. Neuroscience. 2013;244:113–21.
Article
CAS
PubMed
Google Scholar
Rinwa P, Kumar A, Garg S. Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression. PLoS One. 2013;8(4), e61052.
Article
CAS
PubMed
PubMed Central
Google Scholar
Isingrini E, Belzung C, D'Audiffret A, Camus V. Early and late-onset effect of chronic stress on vascular function in mice: a possible model of the impact of depression on vascular disease in aging. Am J Geriatr Psychiatry. 2011;19(4):335–46.
Article
PubMed
Google Scholar
Pan JH, Wang YY, Huang SJ, Mao YR, Chen Z, Zheng J, et al. Establishment of Rat Model of Vascular Depression. Shou Du Yi Ke Da Xue Xue Bao. 2007;28(6):760–2.
CAS
Google Scholar
Choy M, Ganesan V, Thomas DL, Thornton JS, Proctor E, King MD, et al. The chronic vascular and haemodynamic response after permanent bilateral common carotid occlusion in newborn and adult rats. J Cereb Blood Flow Metab. 2006;26(8):1066–75.
Article
PubMed
Google Scholar
Otori T, Katsumata T, Muramatsu H, Kashiwagi F, Katayama Y, Terashi A. Long-term measurement of cerebral blood flow and metabolism in a rat chronic hypoperfusion model. Clin Exp Pharmacol Physiol. 2003;30(4):266–72.
Article
CAS
PubMed
Google Scholar
Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C. Interaction between flavonoids and the blood–brain barrier: in vitro studies. J Neurochem. 2003;85(1):180–92.
Article
CAS
PubMed
Google Scholar
Hwang SL, Shih PH, Yen GC. Neuroprotective effects of citrus flavonoids. J Agric Food Chem. 2012;60(4):877–85.
Article
CAS
PubMed
Google Scholar
Ye J, Lin H, Mu J, Cui X, Ying H, Lin M, et al. Effect of basic fibroblast growth factor on hippocampal cholinergic neurons in a rodent model of ischaemic encephalopathy. Basic Clin Pharmacol Toxicol. 2010;107(6):931–9.
Article
CAS
PubMed
Google Scholar
Shetty AK, Mishra V, Kodali M, Hattiangady B. Blood brain barrier dysfunction and delayed neurological deficits in mild traumatic brain injury induced by blast shock waves. Front Cell Neurosci. 2014;8:232.
PubMed
PubMed Central
Google Scholar
Takeda S, Sato N, Morishita R. Systemic inflammation, blood–brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy. Front Aging Neurosci. 2014;6:171.
PubMed
PubMed Central
Google Scholar
Sato Y, Chin Y, Kato T, Tanaka Y, Tozuka Y, Mase M, et al. White matter activated glial cells produce BDNF in a stroke model of monkeys. Neurosci Res. 2009;65(1):71–8.
Article
CAS
PubMed
Google Scholar
Yoshii A, Constantine-Paton M. Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol. 2010;70(5):304–22.
CAS
PubMed
PubMed Central
Google Scholar
Neeley EW, Berger R, Koenig JI, Leonard S. Prenatal stress differentially alters brain-derived neurotrophic factor expression and signaling across rat strains. Neuroscience. 2011;187:24–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Collen D. The plasminogen (fibrinolytic) system. Thromb Haemost. 1999;82(2):259–70.
CAS
PubMed
Google Scholar
Salles FJ, Strickland S. Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J Neurosci. 2002;22(6):2125–34.
CAS
PubMed
Google Scholar
Eskandari F, Mistry S, Martinez PE, Torvik S, Kotila C, Sebring N, et al. Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk. Metabolism. 2005;54(7):918–24.
Article
CAS
PubMed
Google Scholar
Tsai SJ, Hong CJ, Liou YJ, Yu YW, Chen TJ. Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response. Pharmacogenet Genomics. 2008;18(10):869–75.
Article
CAS
PubMed
Google Scholar
Tsai SJ. The possible role of tissue-type plasminogen activator and the plasminogen system in the pathogenesis of major depression. Med Hypotheses. 2006;66(2):319–22.
Article
CAS
PubMed
Google Scholar
Carrano A, Hoozemans JJ, van der Vies SM, Rozemuller AJ, van Horssen J, de Vries HE. Amyloid Beta induces oxidative stress-mediated blood–brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal. 2011;15(5):1167–78.
Article
CAS
PubMed
Google Scholar
Zlokovic BV. The blood–brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57(2):178–201.
Article
CAS
PubMed
Google Scholar
Mishiro K, Ishiguro M, Suzuki Y, Tsuruma K, Shimazawa M, Hara H. A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice. Neuroscience. 2012;205:39–48.
Article
CAS
PubMed
Google Scholar
Shalev H, Serlin Y, Friedman A. Breaching the blood–brain barrier as a gate to psychiatric disorder. Cardiovasc Psychiatry Neurol. 2009;2009:278531.
Article
PubMed
PubMed Central
Google Scholar
Lehner C, Gehwolf R, Tempfer H, Krizbai I, Hennig B, Bauer HC, et al. Oxidative stress and blood–brain barrier dysfunction under particular consideration of matrix metalloproteinases. Antioxid Redox Signal. 2011;15(5):1305–23.
Article
CAS
PubMed
Google Scholar
Nakaji K, Ihara M, Takahashi C, Itohara S, Noda M, Takahashi R, et al. Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke. 2006;37(11):2816–23.
Article
CAS
PubMed
Google Scholar
Tai SH, Chen HY, Lee EJ, Chen TY, Lin HW, Hung YC, et al. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia. J Pineal Res. 2010;49(4):332–41.
Article
CAS
PubMed
Google Scholar